<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Big Data on Morgan Bye</title><link>https://morganbye.com/tags/big-data/</link><description>Recent content in Big Data on Morgan Bye</description><generator>Hugo</generator><language>en-ca</language><copyright>CC BY-SA 4.0</copyright><lastBuildDate>Fri, 17 May 2024 14:30:00 +0500</lastBuildDate><atom:link href="https://morganbye.com/tags/big-data/index.xml" rel="self" type="application/rss+xml"/><item><title>Flight operations at Boeing</title><link>https://morganbye.com/projects/2020_boeing/</link><pubDate>Fri, 17 May 2024 14:30:00 +0500</pubDate><guid>https://morganbye.com/projects/2020_boeing/</guid><description>&lt;p&gt;&lt;a href="https://services.boeing.com/flight-operations/flight-data-analytics/insight-accelerator"&gt;Insight Accelerator&lt;/a&gt; is a first-of-its-kind predictive maintenance solution that provides powerful advanced analytics and customized alerting – all in an easy-to-use tool. By analyzing full flight data from thousands of onboard sensors, users can derive prognostic insights and create alerting algorithms unique to each airline’s operation.&lt;/p&gt;
&lt;p&gt;Harness the power of built-in augmented analytics to identify patterns of premature component failure to pre-emptively perform maintenance and avoid the high impacts of unwanted disruptions – all without needing data science or advanced programming skills.&lt;/p&gt;</description></item><item><title>Personalized cancer therapy</title><link>https://morganbye.com/projects/2018_bc_cancer/</link><pubDate>Fri, 17 May 2024 14:00:00 +0500</pubDate><guid>https://morganbye.com/projects/2018_bc_cancer/</guid><description>&lt;p&gt;All cells have genomes (DNA genetic codes) that govern their existence. Cancer occurs when the genomes of cells change, leading to uncontrolled cell growth and replication.&lt;/p&gt;
&lt;p&gt;The Personalized Onco-Genomics (POG) Program is BC Cancer’s flagship study in precision medicine and the first program of its kind to deploy whole genome analysis to inform individual treatment planning for patients.&lt;/p&gt;
&lt;p&gt;For each patient, 2 samples are taken, one of &amp;ldquo;normal&amp;rdquo; cells, and one from the cancer. The sequences are then compared in an effort to find variations and mutations between the two which represent the cancer.&lt;/p&gt;</description></item></channel></rss>